Yiwangyichuang: Shareholder Zhang Fan plans to reduce his shareholding by no more than 1%. Yiwangyichuang announced that shareholder Zhang Fan, who holds more than 5% of the company's shares, plans to reduce his shareholding by centralized bidding and/or block trading, and the number of shares to be reduced is no more than 2,369,400, accounting for 1.00% of the company's total share capital. The reduction period is from January 6, 2025 to April 4, 2025. The price range of reduction will be determined according to the market price and trading method at the time of reduction. The reason for Zhang Fan's reduction is based on his own capital demand, and the shares come from the shares issued before the initial public offering, the shares transferred due to equity distribution and the shares transferred by agreement.Gao Weibing: Guangzhou Institute will improve the variety layout of new energy and new materials. On December 12th, 2024 China New Energy and New Materials Industry Conference was held in Guangzhou. Gao Weibing, Party Secretary and Chairman of Guangzhou Futures Exchange, said that in the near future, Guangzhou Futures Exchange will launch polysilicon futures and options to form a linkage with industrial silicon, providing more effective price signals and risk management tools for the photovoltaic industry chain. In the next step, Guangzhou Institute will thoroughly implement the spirit of "Opinions on Strengthening Supervision and Preventing Risks to Promote the High-quality Development of Futures Market", based on the fundamental purpose of serving the real economy and the characteristic orientation of serving the green development, improve the variety layout of new energy and new materials, increase market cultivation, continuously enrich the supervision toolbox, and strive to ensure the safe and stable operation of the market and better serve the needs of the real economy. (China Nonferrous Metals News)Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.
Add 121.3 billion cubic meters! The proven reserves of Fuling shale gas field have exceeded one trillion cubic meters. The reporter learned from China Petrochemical today (12th) that China has made great progress in shale gas exploration. The proven reserves in Nanchuan block of Fuling shale gas field have increased by 121.356 billion cubic meters, and the accumulated proven reserves have reached one trillion cubic meters, which has added protection to national energy security. (CCTV News)Daiwa raised Tesla's target price to $420.Ministry of Health of Gaza: Since October 7, 2023, 44,835 Palestinians have been killed and 106,356 injured in Israeli military attacks on the Gaza.
18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.Xia Yiping, CEO of Extreme Vietnam: I am only a minority shareholder of the company, and Baidu has 80% of the voting rights. I learned from employees inside Extreme Vietnam that Xia Yiping, CEO of Extreme Vietnam, communicated with employee representatives about the company this afternoon. He revealed that the board of directors had a meeting the night before the 11th solution was released, and no agreement was reached on employee social security. It is not up to you to decide the plan that is released only after you get the resolution from the board of directors. "I said that I could take some money to solve the social security problem of employees, but in this case, neither shareholder stood up." He said that he is the CEO of the company, but he is only a minority shareholder and has decision-making power in business, but he has no decision-making power in the development of the company and needs the decision of the board of directors. 80% of the voting rights of the company are in Baidu. Baidu has just conducted a comprehensive audit of the company recently, and there are no problems. (Sina Technology)The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.